NCYT:LON
Novacyt SA
39,50 GBX
arrow_downward
-0,25%(-0,100) 1 d.
16. okt., 16:35:25 GMT+1 · GBX
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: NCYT…
Atvērt
39,60 GBX
Augsta
39,68 GBX
Zema
39,20 GBX
Tirgus kapitalizācija
32,41 milj.
Vid. apjoms
102,63 tūkst.
Apjoms
12,22 tūkst.
Augstākā 52 ned.
86,00 GBX
Zemākā 52 ned.
26,60 GBX
Apgrozībā esošās akcijas
37,66 milj.
Darbinieku skaits
228
Atvērt
39,60 GBX
Augsta
39,68 GBX
Zema
39,20 GBX
Tirgus kapitalizācija
32,41 milj.
Vid. apjoms
102,63 tūkst.
Apjoms
12,22 tūkst.
Augstākā 52 ned.
86,00 GBX
Zemākā 52 ned.
26,60 GBX
Apgrozībā esošās akcijas
37,66 milj.
Darbinieku skaits
228
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
The Motley Fool
·
pirms 45 minūtēm
A Record Number of S&P 500 Companies Issued Upbeat Guidance Before Earnings Season. Should You Buy an Index Fund Now?
MarketBeat
·
pirms 59 minūtēm
Fox Corporation (NASDAQ:FOX) Stock Has Average Price Target of $76.56
Simply Wall Street
·
pirms 1 stundas
What Pacira BioSciences Doubters Got Wrong
Yahoo Finance
·
pirms 22 stundām
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Profils
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Par “Novacyt SA”
ĢenerāldirektorsDavid Allmond
Darbinieki228
Dibināšanas datums2006. gada 3. jūl.
Galvenais birojs-
Sektors-
Tīmekļa vietnenovacyt.com